Opimox 250 Capsule

Opimox 250 is effective against both gram-positive and some gram-negative organisms, including Streptococcus pneumoniae, Haemophilus influenzae, and Escherichia coli. The capsule formulation allows for convenient oral administration with good absorption and bioavailability. Dosage should be individualized based on the severity of infection, patient age, weight, and renal function, typically administered every 8 hours.

Common adverse effects include gastrointestinal disturbances such as nausea, vomiting, and diarrhea, as well as hypersensitivity reactions ranging from rash to anaphylaxis in penicillin-sensitive individuals. Caution is advised in patients with a history of penicillin allergy or renal impairment. Opimox 250 should be used under medical supervision, ensuring adherence to the prescribed regimen to prevent antibiotic resistance and achieve optimal therapeutic outcomes.